All articles by Shalini Nair

  1. ViiV Healthcare receives MA in Europe for Dovato

    The European Commission (EC) has approved ViiV Healthcare’s marketing authorisation application (MAA) for Dovato (dolutegravir/lamivudine), which is indicated to treat…
    Read More…

    3 Jul
  2. Top ten healthcare M&A financial and legal advisers for Q1 2019 revealed

    JP Morgan was the leading financial adviser globally for mergers and acquisitions (M&A) in Q1 2019 in the healthcare sector,…
    Read More…

    20 May
  3. EQT increases offer for Karo Pharma to $694m

    Private investment firm EQT has increased its offer for Sweden-based Karo Pharma to Skr6.15bn ($694m), partly due to an improved…
    Read More…

    3 Jan
  4. Cambrex signs $252m agreement to acquire Avista Pharma

    Generic active pharmaceutical ingredients (APIs) manufacturer Cambrex has signed a $252m definitive agreement to purchase Avista Pharma Solutions (Avista). A…
    Read More…

    21 Nov
  5. Roivant and iNtRON sign licensing deal for SAL200

    Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which is an investigational biologic to…
    Read More…

    20 Nov
  6. ACCC’s appeal over Pfizer Australia ruling on Lipitor dismissed

    The Australian high court has dismissed the Australian Competition and Consumer Commission’s (ACCC) application for special leave to appeal the…
    Read More…

    19 Oct
  7. Changsheng Bio-Technology fined $1.3bn after vaccine scandals

    A Chinese drug watchdog has imposed a fine and asset seizure worth CNY9.1bn ($1.3bn) on Changsheng Bio-Technology following two major…
    Read More…

    18 Oct
  8. Samsung BioLogics may face legal action for alleged accounting breach

    South Korea-based biopharmaceutical company Samsung BioLogics is likely to face disciplinary measures due to an alleged accounting breach. The country’s…
    Read More…

    17 Oct
Close
Close
Close

Go Top